StockNews.com upgraded shares of GSK (NYSE:GSK – Free Report) from a buy rating to a strong-buy rating in a research report ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

GSK has shifted towards a global marketing ... While the new CEO has made some high-profile changes to the company’s management team, there have been some changes to the way the company ...

GSK plc (LON:GSK – Get Free Report) insider Jonathan Symonds bought 1,500 shares of the stock in a transaction on Friday, ...

GSK (GSK) announced headline results from the FIRST-ENGOT-OV44 phase III trial evaluating Zejula and Jemperli in first line advanced ovarian cancer. The trial met its primary endpoint of PFS ...